help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landis, C. A.
Right arrow Articles by Bourne, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landis, C. A.
Right arrow Articles by Bourne, H. R.

Journal of Clinical Endocrinology & Metabolism, Vol 71, 1416-1420, Copyright © 1990 by Endocrine Society


ARTICLES

Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein

CA Landis, G Harsh, J Lyons, RL Davis, F McCormick and HR Bourne
Department of Medicine, University of California, San Francisco 94143.

Activating mutations in the gene for the alpha-chain of Gs, the stimulatory regulator of adenylyl cyclase, have been identified in human GH-secreting pituitary tumors. Using the polymerase chain reaction and allele-specific oligonucleotide hybridization, we screened 25 GH-secreting tumors for the presence of the activating mutations. We also reviewed the clinical charts of the patients from whom the tumors were removed. Of 25 tumors, 10 (40%) contained activating mutations. Patients in the mutation-positive group came to surgery with smaller tumors and had lower GH levels. The activating mutations identify a subgroup of GH-secreting pituitary tumors that probably arise from a shared oncogenic mechanism.


This article has been cited by other articles:


Home page
EndocrinologyHome page
I. Donangelo, S. Gutman, E. Horvath, K. Kovacs, K. Wawrowsky, M. Mount, and S. Melmed
Pituitary Tumor Transforming Gene Overexpression Facilitates Pituitary Tumor Development
Endocrinology, October 1, 2006; 147(10): 4781 - 4791.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. A. Adarichev, R. Vaiskunaite, J. Niu, I. V. Balyasnikova, and T. A. Voyno-Yasenetskaya
G{alpha}13-mediated transformation and apoptosis are permissively dependent on basal ERK activity
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C922 - C934.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. O. Akintoye, C. Chebli, S. Booher, P. Feuillan, H. Kushner, D. Leroith, N. Cherman, P. Bianco, S. Wientroub, P. G. Robey, et al.
Characterization of gsp-Mediated Growth Hormone Excess in the Context of McCune-Albright Syndrome
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5104 - 5112.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. D. Kineman, L. T. Teixeira, G. V. Amargo, K. T. Coschigano, J. J. Kopchick, and L. A. Frohman
The Effect of GHRH on Somatotrope Hyperplasia and Tumor Formation in the Presence and Absence of GH Signaling
Endocrinology, September 1, 2001; 142(9): 3764 - 3773.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Peri, B. Conforti, S. Baglioni-Peri, P. Luciani, F. Cioppi, L. Buci, S. Corbetta, E. Ballaré, M. Serio, and A. Spada
Expression of Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Responsive Element Binding Protein and Inducible-cAMP Early Repressor Genes in Growth Hormone-Secreting Pituitary Adenomas with or without Mutations of the Gs{{alpha}} Gene
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2111 - 2117.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Barlier, I. Pellegrini-Bouiller, G. Gunz, A. J. Zamora, P. Jaquet, and A. Enjalbert
Impact of gsp Oncogene on the Expression of Genes Coding for Gs{alpha}, Pit-1, Gi2{alpha}, and Somatostatin Receptor 2 in Human Somatotroph Adenomas: Involvement in Octreotide Sensitivity
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2759 - 2765.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
S. L. Asa and S. Ezzat
The Cytogenesis and Pathogenesis of Pituitary Adenomas
Endocr. Rev., December 1, 1998; 19(6): 798 - 827.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Barlier, G. Gunz, A. J. Zamora, I. Morange-Ramos, D. Figarella-Branger, H. Dufour, A. Enjalbert, and P. Jaquet
Pronostic and Therapeutic Consequences of Gs{alpha} Mutations in Somatotroph Adenomas
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1604 - 1610.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Lania, L. Persani, E. Ballaré, S. Mantovani, M. Losa, and A. Spada
Constitutively Active Gs{alpha} Is Associated with an Increased Phosphodiesterase Activity in Human Growth Hormone-Secreting Adenomas
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1624 - 1628.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. R. Peacey, A. A. Toogood, and S. M. Shalet
Hypothalamic Dysfunction in "Cured" Acromegaly Is Treatment Modality Dependent
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1682 - 1686.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Daniely, A. Aviram, E. F. Adams, M. Buchfelder, G. Barkai, R. Fahlbusch, B. Goldman, and E. Friedman
Comparative Genomic Hybridization Analysis of Nonfunctioning Pituitary Tumors
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1801 - 1805.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Shimon and S. Melmed
Pituitary Tumor Pathogenesis
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1675 - 1681.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. L. Boguszewski, G. Johannsson, B.-A. Bengtsson, A. Johansson, B. Carlsson, and L. M. S. Carlsson
Circulating Non-22-Kilodalton Growth Hormone Isoforms in Acromegalic Men before and after Transsphenoidal Surgery
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1516 - 1521.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society